What Makes Zevra Therapeutics (ZVRA) a Good Fit for 'Trend Investing'

Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting the utility of a specific screening strategy to identify stocks with strong fundamentals and positive price momentum [1][2]. Group 1: Stock Screening Strategy - The "Recent Price Strength" screen is designed to identify stocks with sufficient fundamental strength to maintain their upward price trends, focusing on those trading in the upper portion of their 52-week high-low range, indicating bullishness [3]. - Zevra Therapeutics (ZVRA) is highlighted as a strong candidate for trend investing, having increased by 43.9% over the past 12 weeks, reflecting investor confidence in its potential [4]. - ZVRA has maintained a price increase of 0.9% over the last four weeks, indicating that the upward trend is still intact, and it is currently trading at 85.2% of its 52-week high-low range, suggesting a potential breakout [5]. Group 2: Fundamental Strength - ZVRA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, which are critical for near-term price movements [6]. - The stock also has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. - The article suggests that the price trend for ZVRA is unlikely to reverse soon, indicating a favorable outlook for investors [8].